@newsramp.comThe American Heart Association will honor Dr. Katherine Tuttle with its 2026 Clinical Research Prize for transforming chronic kidney disease treatment through landmark research on SGLT2 inhibitors and GLP-1 therapies. #KidneyDisease #Cardiology
@quartzmedia.bsky.socialDoctors say hesitation — not ignorance — is killing heart attack patients #HeartHealth #Cardiology
@newsramp.comThe American Heart Association will honor Dr. Pradeep Natarajan with its 2026 Population Research Prize for transforming cardiovascular disease prevention through human genetics and large population studies. The award will be presented at Scientific Sessions in Chicago this November. #Cardiology #Pr
@newsramp.comVanderbilt's Dr. Annet Kirabo wins the 2026 Joseph A. Vita Award from the American Heart Association for groundbreaking research linking immune activation and inflammation to hypertension and cardiovascular disease. #Hypertension #Cardiology
@newsramp.comNew research shows maternal cardiovascular disease rose from 1% to 7% between 2001-2019. Dr. Emily Lau of Mass General Brigham wins the 2026 AHA Dr. Nanette K. Wenger Research Goes Red Award for this critical work on pregnancy and heart health. #WomensHealth #Cardiology
@cvia-journal.orgThe 37th Great Wall International Congress of #Cardiology and Asian Heart Society Congress 2026 serves as a platform for sharing evidence, fostering collaboration, and advancing discussions in #CardiovascularResearch and clinical practice.
Explore: doi.org/10.15212/CVI...
@cardiophoenix.bsky.socialEarlier structural suspicion means a patient reaches imaging with a specific question, not as the end of a long chain of exclusions.
@cvia-journal.orgRivaroxaban reduced ischemic stroke risk in #AcuteMyocardialInfarction patients with #AtrialFibrillation, but mortality and bleeding outcomes were unchanged. Findings refine anticoagulant strategies. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
@dgk-org.bsky.social⚡Who responds best to CRT-D upgrade? The new post-hoc analysis of the BUDAPEST-CRT Upgrade study, published in #CriC (@springernature.com), identified e.g. non-ischemic etiology, high RV pacing burden at enrollment. Full study:
➡️ link.springer.com/article/10.1...
#DGK #Cardiology #CardioSky
@drjcast.bsky.socialTold my physics-teacher husband about the impella controller recall. He just stared at me and said "firmware?" in the exact tone you'd expect.
@diazgiles.bsky.socialCliente: Cardiología Clínica & Ecocardiografía
Brief: Implementar un isotipo delicado y femenino sin tecnicismos
Solución: Líneas delgadas cuyas ramificaciones representan arterias, detalles florales
¿Deseas crear tu imagen médica? Mándame mensaje
@jcardfail.bsky.socialWhat makes JCF impactful? Ask the people behind it. 💜
Our Impact Factor has grown 48% since 2023, from 6.7 to 9.9. But our growth is about more than a number.
It reflects a global community advancing #HeartFailure research together.
@cvia-journal.orgFindings show men and women with #PulmonaryArterialHypertension share comparable disease patterns, with complexity rising with age. This novel strategy may guide comorbidity prevention. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
@newsen.bsky.socialAtrium Therapeutics Secures $50 Million in Strategic Private Placement Financing #United_States #San_Diego #RNA_Therapeutics #Cardiology #Atrium_Therapeutics
@cvia-journal.orgLarge language models GPT-5.2 and DeepSeek-V3.2 improved CMR report accessibility for patients, but radiologist oversight remained essential. #Cardiology #CVIA
#OpenAccess: cvia-journal.org/large-langua...
@hollerdoc.bsky.socialAbbott's heart failure monitor just got smarter. My stethoscope is older than some of my patients and still works just fine.
@marcusreedhf.bsky.socialCardiac MRI is how they actually see tissue, and now the Achieva 3.0T is on a Class II recall. Makes a man wonder how many of those scans came off busted machines.
@hollerdoc.bsky.socialfella new drug-eluting balloon cleared by FDA. Fine. Out here, I'm still trying to get a STEMI to a cath lab in under 90 minutes. Different universe.
@news.zovintus.comSwiss researchers are launching groundbreaking human trials using targeted lipid-nanoparticles to repair defective cardiac tissue, bypassing risky systemic viral vectors for precision heart healing.
#GeneEditing #Cardiology #Zovintus
[Image by AI]